Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cancers|January 23, 2024
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination-Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica LombardaGiuseppe Rossi, Erika Borlenghi, Patrizia Zappasodi, et al.
Transplantation|December 10, 2009
Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantationErica Dander, Adriana Balduzzi, Greta Zappa, et al.
Haematologica|October 16, 2012
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter studyLivio Pagano, Caterina Giovanna Valentini, Alessandro Pulsoni, et al.
Annals of Hematology|March 24, 2023
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL studyDavide Lazzarotto, Ilaria Tanasi, Antonella Vitale, et al.
Hematological Oncology|January 13, 2026
NPM1 and IDH1/2 Mutations Show Limited Prognostic Impact in Relapsed/Refractory AML: Evidence From the AVALON CohortCalogero Vetro, Irene Azzali, Elisabetta Petracci, et al.
American Journal of Hematology|December 11, 2024
Efficacy of Midostaurin Combined With Intensive Chemotherapy in Core Binding Factor Leukemia: A Phase II Clinical TrialRoberto Cairoli, Arianna Gatti, Giovanni Grillo, et al.
The Lancet. Oncology|February 29, 2024
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 studyNaval G Daver, Pau Montesinos, Daniel J DeAngelo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2017
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell TransplantationMartino Introna, Federico Lussana, Alessandra Algarotti, et al.
Cancers|August 16, 2020
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)Silvia Salmoiraghi, Roberta Cavagna, Pamela Zanghì, et al.
Blood Advances|April 6, 2019
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AMLRenato Bassan, Tamara Intermesoli, Arianna Masciulli, et al.
Pageof 5